Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Multicenter, Open-Label Phase III Study to Evaluate the Safety and Efficacy of ISU302 (Imiglucerase for Injection) in Patients With Type 1 Gaucher Disease
Brief Summary: The purpose of this study is to evaluate the safety and efficacy of ISU302 in patients with Type 1 Gaucher disease.